Synthesis and characterization of surface-modified PBLG nanoparticles for bone targeting: In vitro and in vivo evaluations

Journal of Pharmaceutical Sciences

Volumn 100, Issue 11, 2011, Pages 4877-4887

  Özcan, Ipek ^a   Bouchemal, Kawthar ^b   Segura Sánchez, Freimar ^b,c   Özer, Özgen ^a   Güneri, Tamer ^a   Ponchel, Gilles ^b  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Alendronate; Bone targeting; Nanoparticles; PEGylation; Poly( benzyl l glutamate)

Indexed keywords

ALENDRONIC ACID; FLUORESCEIN ISOTHIOCYANATE; HYDROXYAPATITE; MACROGOL; NANOPARTICLE; POLY GAMMA BENZYL GLUTAMATE; POLYPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE TARGETED DRUG DELIVERY; CALCIUM BINDING; DRUG DELIVERY SYSTEM; DRUG LABELING; HYDROPHILICITY; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; ISOTHERMAL TITRATION CALORIMETRY; LIGHT SCATTERING; MOLECULARLY TARGETED THERAPY; NONHUMAN; PARTICLE SIZE; RAT; RETICULOENDOTHELIAL SYSTEM; RING OPENING METATHESIS POLYMERIZATION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 80053249626     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22678     Document Type: Article

References (42)

1. Moghimi SG, Hunter AC, Murray JC. 2001. Long-circulating and target specific nanoparticles: Theory to practice. Pharmacol Rev 53:283-318.
2. Stella B, Arpicco S, Peracchia MT, Desmaele D, Hoebeke J, Renoir M, D'Angelo J, Cattel L, Couvreur P. 2000. Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci 89:1452-1464.
3. Wang G, Uludag H. 2008. Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. Exp Op Drug Deliv 5:499-515.
4. Hirabayashi H, Takahashi T, Fujisaki J, Masunaga T, Sato S, Hiroi J, Tokunaga Y, Kimura S, Hata T. 2001. Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS). J Control Release 70:183-191.
5. Kim K, Fisher JP. 2007. Nanoparticle technology in bone tissue engineering. J Drug Target 15:241-252.
6. Salerno M, Cenni E, Fotia C, Avnet S, Granchi D, Castelli F, Micieli D, Pignatello R, Capulli M, Rucci N, Angelucci A, Del Fattore A, Teti A, Zini N, Giunti A, Baldini N. 2010. Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases. Curr Cancer Drug Targets 10:649-659.
7. Cenni E, Granchi D, Avnet S, Fotia C, Salerno M, Micieli D, Sarpietro MG, Pignatello R, Castelli F, Baldini N. 2008. Biocompatibility of poly(d, l-lactide-co-glycolide) nanoparticles conjugated with alendronate. Biomater 29:1400-1411.
8. Hengst V, Oussoren C, Kissel T, Storm G. 2007. Bone targeting potential of bisphosphonate-targeted liposomes: Preparation, characterization and hydroxyapatite binding in vitro. Int J Pharm 331:224-227.
9. Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A. 2008. Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells. Biomater 29:790-796.
10. Huang W, Wang Y, Ren L, Du C, Shi X. 2009. A novel PHBV/HA microsphere releasing system loaded with alendronate. Mater Sci Eng C 29:2221-2225.
11. Li H, Tian Z, Wang M, Zhang A, Feng Z. 2008. Synthesis and characterization of novel triblock copolymers comprising poly(tetrahydrofuran) as a central block and poly(γ-benzyl l-glutamate)s as outer blocks. Front Mater Sci China 2:84-90.
12. Ignjatovic NL, Liu CZ, Czernuszka JT, Uskokovic DP. 2007. Micro- and nano-injectable composite biomaterials containing calcium phosphate coated with poly(dl-lactide-co-glycolide). Acta Biomater 3:927-935.
13. Owens DE, Peppas NA. 2006. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93-102.
14. Harris JM, Chess RB. 2003. Effect of PEGylation on pharmaceuticals. Nat Rev Drug Discov 2:214-221.
15. Wan Y, Chen W, Yang J, Bei J, Wang S. 2003. Biodegradable poly(llactide)-poly(ethylene glycol) multiblock copolymer: Synthesis and evaluation of cell affinity. Biomater 24:2195-2203.
16. Martinez-Barbosa EM, Montembault V, Cammas-Marion S, Ponchel G, Fontaine L. 2007. Synthesis and characterization of novel poly(γ-benzyl-l-glutamate) derivatives tailored for the preparation of nanoparticles of pharmaceutical interest. Polym Int 56:317-324.
17. Segura-Sánchez F, Montembault V, Fontaine L, Martínez-Barbosa EM, Bouchemal K, Ponchel G. 2010. Synthesis and characterization of functionalized poly(γ-benzyl-l-glutamate) derivates and corresponding nanoparticles preparation and characterization. Int J Pharm 387:244-252.
18. Kim TH, Park TG. 2004. Critical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheres. Int J Pharm 271:207-214.
19. Jiayin Z, Jianmin W. 2006. Preparation and characterization of the fluorescent chitosan nanoparticle probe. Chin J Anal Chem 34:1555-1559.
20. Segura-Sanchez F, Bouchemal K, Lebas G, Vauthier C, Santos-Magalhaes NS, Ponchel G. 2009. Elucidation of the complexation mechanism between (+)-usnic acid and cyclodextrins studied by isothermal titration calorimetry and phase-solubility diagram experiments. J Mol Recognit 22:232-241.
21. Yalman RG, Bruegemann W, Baker PT, Garn SM. 1959. Volumetric determination of calcium in presence of phosphate. Anal Chem 31:1230-1233.
22. Bravo-Osuna I, Millotti G, Vauthier C, Ponchel G. 2007. In vitro evaluation of calcium binding capacity of chitosan and thiolated chitosan poly(isobutyl cyanoacrylate) core-shell nanoparticles. Int J Pharm 38:284-290.
23. Bansal G, Wright JEI, Zhang S, Zernicke RF, Uludag H. 2005. Imparting mineral affinity to proteins with thiol-labile disulfide linkages. J Biomed Mater 74:618-628.
24. Shinoda H, Adamek G, Felix R, Fleisch H, Schenk R, Hagan P. 1983. Structure-activity relationships of various bisphosphonates. Calcif Tissue Int 35:87-99.
25. Dawson B, Trapp RG. 2001. Basic and clinical biostatistics. McGraw Hill, USA pp 161-182.
26. Mori H, Iwata M, Ito S, Endo T. 2007. Ring-opening polymerization of γ-benzyl-l-glutamate-N-carboxyanhydride in ionic liquids. Polym 48:5867-5877.
27. Casolaro M, Casolaro I, Spreafico A, Capperucci C, Frediani B, Marcolongo R, Margiotta N, Ostuni R, Mendichi R, Samperi F, Ishii T, Ito Y. 2006. Novel therapeutic agents for bone resorption. Part I. Synthesis and protonation thermodynamics of poly(amido-amine)s containing bis-phosphate residues. Biomacromol 7:3417-3427.
28. Jeong YI, Seo SJ, Park IK, Lee HC, Kang IC, Akaike T, Cho CS. 2005. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(γ-benzyl l-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharm 296:151-161.
29. Martinez-Barbosa E, Cammas-Marion S, Bouteiller L, Vauthier C, Ponchel G. 2009. PEGylated degradable composite nanoparticles based on mixtures of PEG-b-Poly(γ-benzyl l-glutamate) and Poly(γ-benzyl l-glutamate). Bioconjugate Chem 20:1490-1496.
30. Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MNV. 2007. Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release 119:77-85.
31. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC. 2007. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomater 28:869-887.
32. Choi SW, Kim JH. 2007. Design of surface-modified poly(d, l-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. J Control Release 122:24-30.
33. Wang D, Miller S, Sima M, Kopeckova P, Kopecek J. 2003. Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems. Bioconjugate Chem 14:853-859.
34. Riddick TM, Ed. 2007. Control of colloid stability. In Zeta potential. Staunton, Virginia: Zeta-Meter Inc., pp 198-200.
35. Yoncheva K, Lizarraga E, Irache JM. 2005. Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): Preparation and evaluation of their bioadhesive properties. Eur J Pharm Sci 24:411-419.
36. Peracchia MT, Vauthier C, Desmaele D, Gulik A, Dedieu JC, Demoy M, d'Angelo J, Couvreur P. 1998. Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer. Pharm Res 15:550-556.
37. Zhao J, Wu J. 2006. Preparation and characterization of the fluorescent chitosan nanoparticle probe. Chin J Anal Chem 34:1555-1559.
38. Bouchemal K. 2008. New challenges for pharmaceutical formulations and drug delivery systems characterization using isothermal titration calorimetry. Drug Discov Today 13:960-972.
39. Pan H, Sima M, Kopeckova P, Wu K, Gao S, Liu J, Wang D, Miller SC, Kopecek J. 2008. Biodistribution and pharmacokinetic studies of bone-targeting N-(2-hydroxypropyl) methacrylamide copolymer-alendronate conjugates. Mol Pharm 5:548-558.
40. Ozcan I, Segura-Sanchez F, Bouchemal K, Sezak M, Ozer O, Guneri T, Ponchel G. 2010. Pegylation of poly(γ-benzyl-l-glutamate) nanoparticles is efficient for avoiding MPS capture in rats. Int J Nanomed 5:1103-1111.
41. Woodard JC, Burkhardt JE, Lee W. 2002. Bones and joints. In Handbook of toxicologic pathology; Haschek WM, Rousseaux CG, Wallig MA, Eds. 2nd ed., Vol. 2. Academic Press: New York, pp 457-508.
42. Zhang S, Gangal G, Uludag H. 2007. 'Magic bullets' for bone diseases: Progress in rational design of boneseeking medicinal agents. Chem Soc Rev 36:507-531.